The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer (NSCLC) patients.
 
Andrea S. Fung
No Relationships to Disclose
 
Maryam Karimi
No Relationships to Disclose
 
Stefan Michiels
Consulting or Advisory Role - Biophytis; Hexal; IDDI; Janssen-Cilag; QuintilesIMS; Roche; Sensorion
Patents, Royalties, Other Intellectual Property - Co-inventor of patent WO2018002385A1 on prognostic gene score in early breast cancer
 
Lesley Seymour
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - AstraZeneca (Inst); Bayer (Inst); Merck (Inst); Novartis (Inst); Senhwa Biosciences (Inst)
 
Elisabeth Brambilla
No Relationships to Disclose
 
Thierry Le Chevalier
Honoraria - AstraZeneca; Merck Serono
 
Jean-Charles Soria
Honoraria - AstraZeneca/MedImmune; Merus; MSD Oncology; Pfizer; Roche/Genentech; Symphogen
 
Robert Arthur Kratzke
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - AstraZeneca; Merck
Speakers' Bureau - AstraZeneca; Merck
 
Stephen L. Graziano
No Relationships to Disclose
 
Siddhartha Devarakonda
No Relationships to Disclose
 
Ramaswamy Govindan
Honoraria - Abbvie; Genentech/Abbvie; Geneplus
Consulting or Advisory Role - Abbvie; Achilles Therapeutics; Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech/Roche; GlaxoSmithKline; Ignyta; Janssen; Jounce Therapeutics; Lilly; Merck Serono; Nektar; Pfizer; Phillips Gilmore Oncology; Roche
 
Ming-Sound Tsao
No Relationships to Disclose
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Merck Serono; Merck Sharp & Dohme; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck Serono
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merrimack (Inst); Pfizer (Inst); Roche Canada (Inst)